Home » Clinical Trials » Search Clinical Trials

Last updated on August 2019

A Study of Gefapixant (MK-7264) in Japanese Adult Participants With Refractory or Unexplained Chronic Cough (MK-7264-038)

Brief description of study

The primary objective of this study is to evaluate the number of adverse events (AEs)and discontinuation due to AEs through up to 52 weeks of treatment with gefapixant in Japanese adult participants with refractory or unexplained chronic cough.

Clinical Study Identifier: NCT03696108

Start Over

Chubu Rosai Hospital ( Site 3839)

Nagoya, Japan

Oishi Clinic ( Site 3818)

Kasuya-gun, Japan

National Hospital Organization Fukuokahigashi Medical Center ( Site 3849)

Koga, Japan

Nagata Hospital ( Site 3815)

Yanagawa, Japan

National Hospital Organization Shibukawa Medical Center ( Site 3843)

Shibukawa, Japan

Kobe City Hospital Organization Kobe City Medical Center West Hospital ( Site 3868)

Kobe, Japan

National Hospital Organization Mito Medical Center ( Site 3846)

Higashiibaraki-gun, Japan

JA Toride Medical Center ( Site 3822)

Toride, Japan

National Hospital Organization Kasumigaura Medical Center ( Site 3844)

Tsuchiura, Japan

Japan Community Health care Organization Kanazawa Hospital ( Site 3817)

Kanazawa, Japan

Matsusaka City Hospital ( Site 3825)

Matsusaka, Japan

Koyama Medical Clinic ( Site 3838)

Matsumoto, Japan

Sasaki Naika Clinic ( Site 3872)

Sakai, Japan

Sugiura Clinic ( Site 3806)

Kawaguchi, Japan

National Hospital Organization Matsue Medical Center ( Site 3848)

Matsue, Japan

JapanOrganizationOfOccupationalHealthAndSafety HamamatsuRosaiHospital ( Site 3821)

Hamamatsu, Japan

Hamamatsu Medical Center ( Site 3866)

Hamamatsu, Japan

National Hospital Organization Tenryu Hospital ( Site 3823)

Hamamatsu, Japan

Kiheibashi Otolaryngology ( Site 3828)

Kodaira, Japan

Akita University Hospital ( Site 3851)

Akita, Japan

Gifu Prefectural General Medical Center ( Site 3824)

Gifu, Japan

Tochigi Takao Clinic ( Site 3833)

Kagoshima, Japan

Nagano Red Cross Hospital ( Site 3859)

Nagano, Japan

Saiseikai Niigata Daini Hospital ( Site 3831)

Niigata, Japan

Oita Red Cross Hospital ( Site 3837)

Oita, Japan

Yamagata Clinic ( Site 3813)

Oita, Japan

Chibana Clinic ( Site 3809)

Okinawa, Japan

Ito ENT Clinic ( Site 3816)

Shizuoka, Japan

Kindai University Hospital ( Site 3871)

Osakasayama, Japan

Fukui-ken Saiseikai Hospital ( Site 3874)

Fukui, Japan

Saiseikai Niigata Hospital ( Site 3831)

Niigata, Japan

The Fraternity Memorial Hospital ( Site 3873)

Tokyo, Japan

Nagaoka Red Cross Hospital ( Site 3877)

Nagaoka, Japan

Idaimae Minamiyojo Int Clinic ( Site 3903)

Sapporo, Japan

Kishiwada City Hospital ( Site 3880)

Kishiwada, Japan

Nihonbashi Egawa Clinic ( Site 3805)

Tokyo, Japan

Ebisu Clinic Koukokukai Medical Corporation ( Site 3804)

Tokyo, Japan

Kono Medical Clinic ( Site 3894)

Tokyo, Japan

Medical Corporation Kouwakai Kouwa Clinic ( Site 3895)

Tokyo, Japan

Tohno Chuo Clinic ( Site 3883)

Mizunami, Japan

Komatsu Municipal Hospital ( Site 3892)

Komatsu, Japan

Fujisawa City Hospital ( Site 3891)

Fujisawa, Japan

Association of Healthcare Corporation Koukankai Koukan Clinic ( Site 3878)

Kawasaki, Japan

Kawaguchi Respiratory Clinic ( Site 3890)

Higashiosaka, Japan

Shimonoseki City Hospital ( Site 3902)

Shimonoseki, Japan

Tokyo Metropolitan Geriatric Hospital ( Site 3905)

Tokyo, Japan

National Hospital Organization Nagoya Medical Center ( Site 3898)

Nagoya, Japan

Kinki Central Hospital ( Site 3910)

Itami, Japan

Kamei Internal Medicine and Respiratory Clinic ( Site 3904)

Takamatsu, Japan

Saiseikai Yokohamashi Nanbu Hospital ( Site 3897)

Yokohama, Japan

National Hospital Organization Minami-Okayama Medical Center ( Site 3901)

Tsukubo-gun, Japan

National Hospital Organization Kinki-chuo Chest Medical Center ( Site 3900)

Sakai, Japan

National Hospital Organization Tokyo National Hospital ( Site 3909)

Kiyose, Japan

A Study of Gefapixant (MK-7264) in Japanese Adult Participants With Refractory or Unexplained Chronic Cough (MK-7264-038)

Brief description of study

Volunteer Sign-up